KD Logo

Recent Insider Activity Suggests Potential Gains for Bioventus Inc (BVS)

Bioventus Inc’s recently made public that its SVP & CFO Singleton Mark Leonard unloaded Company’s shares for reported $51350.0 on Jun 21 ’24. In the deal valued at $5.57 per share,9,219 shares were sold. As a result of this transaction, Singleton Mark Leonard now holds 84,895 shares worth roughly $0.49 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, D’Adamio Anthony sold 5,904 shares, generating $32,885 in total proceeds. Upon selling the shares at $5.57, the SVP & General Counsel now owns 95,576 shares.

Before that, CHURCH KATRINA J sold 2,559 shares. Bioventus Inc shares valued at $14,254 were divested by the SVP & Chief Compliance Officer at a price of $5.57 per share. As a result of the transaction, CHURCH KATRINA J now holds 41,199 shares, worth roughly $0.24 million.

Canaccord Genuity upgraded its Bioventus Inc [BVS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who increased its forecast for the stock in early August from “a Hold” to “a Buy”. Craig Hallum also remained covering BVS and has decreased its forecast on November 22, 2022 with a “Hold” recommendation from previously “Buy” rating. JP Morgan revised its rating on November 09, 2022. It rated BVS as “an Underweight” which previously was an “an Overweight”.

Price Performance Review of BVS

On Tuesday, Bioventus Inc [NASDAQ:BVS] saw its stock jump 0.87% to $5.78. Over the last five days, the stock has gained 5.47%. Bioventus Inc shares have risen nearly 9.68% since the year began. Nevertheless, the stocks have risen 100.00% over the past one year. While a 52-week high of $7.04 was reached on 06/12/24, a 52-week low of $2.71 was recorded on 04/30/24. SMA at 50 days reached $5.68, while 200 days put it at $4.69. A total of 0.83 million shares were traded, compared to the trading of 1.03 million shares in the previous session.

Levels Of Support And Resistance For BVS Stock

The 24-hour chart illustrates a support level at 5.58, which if violated will result in even more drops to 5.39. On the upside, there is a resistance level at 6.01. A further resistance level may holdings at 6.25. The Relative Strength Index (RSI) on the 14-day chart is 45.69, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.59%. Stochastics%K at 26.90% indicates the stock is a holding.

Most Popular